Dr. William Kim is a senior associate in the firm's Intellectual Property Department. He joined the firm in 2002. Dr. Kim focuses his practice on life sciences patent strategy and prosecution.
Practice
Dr. Kim's patent practice includes US and foreign patent prosecution, non-infringement and invalidity opinions, patentability assessments, diligence, competitive intelligence, reissue and reexamination, and US patent interference work for biotechnology and pharmaceutical companies and academic institutions. In addition to patent prosecution and counseling, Dr. Kim's practice includes pre-suit investigation, litigation and appellate support for life science matters.
Dr. Kim has worked on a wide range of technologies, including therapeutic antibodies, methods for making and screening therapeutic antibodies, various small molecule drugs, oncolytic viruses, methods for screening anti-viral drugs, genetic and cellular diagnostics, recombinant vaccines, stem cell technologies, siRNA, liposome-mediated drug delivery, and three-dimensional tissue systems.
Recent Highlights
- Successful termination of a patent interference prior to the motions phase
- Successful judgment on priority for a patent interference
- Reverse IP diligence on a multibillion dollar pharmaceutical merger
Professional Activities
Dr. Kim was a Norman and Rosita Winston postdoctoral fellow and a Cancer Research Institute postdoctoral fellow in the Laboratory of Molecular Genetics and Immunology at The Rockefeller University. He received a PhD, with distinction, in the Cellular, Molecular and Biophysical Studies program from Columbia University. His thesis research focused on the molecular and genetic mechanisms of T-cell development. Dr. Kim is a member of the American Intellectual Property Law Association.